ALLO Allogene Therapeutics, Inc.
$1.78▲ +1.14%
Healthcare
Other
After hours
$1.77▼ -0.51%
Sep 11, 7:52 PM ET
Volume 3.88M
Avg Volume (10D) 5.16M
Key Metrics & Fundamentals
Market Cap
$614.97M
P/E Ratio
–
Div Yield
–%
52W Range
1.04 - 4.46
% vs 50 MA
-10.35%
% vs 200 MA
-10.85%
RSI-14
37.1
MACD Histogram
-0.0400
Beta (1Y vs SPY)
2.20
Free Cash Flow
-$32.15M
Gross Rev
$4.64M
Gross Profit
$4.64M
EBITDA
-$39.69M
COGS
–
Operating Exp
$51.56M
Operating Income
-$46.92M
EBIT
-$46.92M
Pretax Income
-$42.68M
Net Income
-$42.68M
EPS (Diluted)
-0.13
Price & Volume History
Loading chart…
Recent News
Allogene Therapeutics (ALLO) Down 11.1% Since Last Earnings Report: Can It Rebound?
Zacks · Sep 11, 2026 3:30 PM
Allogene Therapeutics CFO Geoffrey Parker to Retire
MT Newswires · Sep 2, 2026 12:45 PM
Autoimmune CAR-T faces tough questions after Novartis, Bristol Myers study halts
BioPharma Dive · Sep 2, 2026 12:32 PM
Allogene Therapeutics Announces Retirement of Chief Financial Officer Geoffrey Parker
GlobeNewswire · Sep 2, 2026 12:30 PM
Allogene Therapeutics Announces Participation in September Investor Conference
GlobeNewswire · Aug 31, 2026 12:30 PM
Allogene (ALLO) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 19, 2026 8:58 PM
Is Allogene Therapeutics (ALLO) Stock Outpacing Its Medical Peers This Year?
Zacks · Aug 17, 2026 1:40 PM
Allogene Therapeutics' Q2 Earnings Beat Estimates on Lower R&D Costs
Zacks · Aug 13, 2026 5:47 PM
Allogene Therapeutics Remains Attractive Given Valuation, Clinical Strategy, RBC Says
MT Newswires · Aug 13, 2026 3:33 PM
Allogene Therapeutics, Inc. Q2 2026 Earnings Call Summary
Moby · Aug 13, 2026 12:30 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See ALLO's money flow as a full page
Social Sentiment
Avg +0.33 · 3 posts
DDTradespaceX IPO is literally free money if you know what youre doing
r/wallstreetbets · Jun 12, 2026
The post expresses frustration with a failed IPO allocation for ALLO and mentions specific investment strategies related to it.
negative
-0.60
DDPriceTargetDiscussionALLO is the stock with room to grow
r/wallstreetbets · Oct 15, 2024
The author expresses strong belief in ALLO's future growth and sets a price target.
very_positive
+0.80
DDNewsDiscussionAllogene Therapeutics is definitely moving on #ALLO
r/wallstreetbets · Aug 12, 2024
The post expresses optimism about Allogene's technology and pipeline, indicating a bullish sentiment.
positive
+0.80
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.